FY2025 EPS Forecast for DENTSPLY SIRONA Reduced by Analyst

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at Barrington Research decreased their FY2025 earnings per share estimates for DENTSPLY SIRONA in a research note issued on Monday, November 10th. Barrington Research analyst M. Petusky now expects that the medical instruments supplier will post earnings of $1.60 per share for the year, down from their prior estimate of $1.85. Barrington Research currently has a “Outperform” rating and a $14.00 target price on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q3 2026 earnings at $0.38 EPS and Q4 2026 earnings at $0.37 EPS.

A number of other brokerages have also weighed in on XRAY. JPMorgan Chase & Co. cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. UBS Group reduced their price target on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research report on Tuesday, October 28th. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $10.98 on Tuesday. The business has a fifty day moving average of $12.86 and a 200 day moving average of $14.45. DENTSPLY SIRONA has a 1 year low of $10.69 and a 1 year high of $20.59. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market capitalization of $2.19 billion, a price-to-earnings ratio of -2.32, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.During the same quarter last year, the business earned $0.50 earnings per share. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Arizona State Retirement System boosted its stake in shares of DENTSPLY SIRONA by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after acquiring an additional 807 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock worth $983,000 after purchasing an additional 861 shares during the period. Gabelli Funds LLC raised its holdings in DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock worth $1,464,000 after purchasing an additional 1,000 shares during the period. True Wealth Design LLC boosted its position in DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after purchasing an additional 1,181 shares in the last quarter. Finally, Sivia Capital Partners LLC grew its holdings in DENTSPLY SIRONA by 5.3% in the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after purchasing an additional 1,293 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.